Executive Profile

R. Gordon Douglas Jr., M.D. Executive Chairman, Aeras Global TB Vaccine Foundation

Age	Total Calculated Compensation	This person is connected to 8 Board Members in 8 different organizations across 9 different industries. See Board Relationships
77	--

Background

Dr. R. Gordon Douglas, Jr., M.D. serves as a Consultant of Vaccine Research Center of National Institutes of Health (NIH). Dr. Douglas serves as a Director of Strategic Planning for National Institutes of Health and Dale and Betty Bumpers Vaccine Research Center. He retired in April 1999 from Merck & Co. Inc., where he served as President of the Merck Vaccine Division since 1991, responsible for the research, development, manufacturing, and marketing of Merck's vaccine ... products from 1989 to May 1999. He served as a Professor of Medicine and Physician-in-Chief at New York Hospital from 1982 to 1990. He held a variety of roles at University Of Rochester School of Medicine between 1970 and 1982 and also served as Head of its Infectious Disease Unit. Dr. Douglas joined Merck in 1989. He served as Physician and Academician, specializing in infectious diseases. His teaching and administrative affiliations included Baylor College of Medicine, University of Rochester School of Medicine, and Cornell University Medical College. His medical practice included affiliations with The New York Hospital, Memorial Sloan-Kettering Cancer Center, The Rockefeller University Hospital and North Shore University Hospital. He served as a visiting professor at a number of medical schools and as a Consultant to several pharmaceutical and biomedical companies. Dr. Douglas has been the Chairman of the Board of MiddleBrook Pharmaceuticals, Inc. (also called as Advancis Pharmaceutical Corp.), since February 2, 2006. He serves as the Chairman of the Board of Vical Inc. He serves as Chairman of NovaDigm Therapeutics, Inc. He serves as the Chairman of the Advisory Board of EluSys Therapeutics Inc. Dr. Douglas serves as Executive Chairman of the Board of the Aeras Global TB Vaccine Foundation. He served as Chairman of NovaDigm Therapeutics Inc. since December 2009. He served as the Chairman of the Department of Medicine of Cornell University Medical College. Dr. Douglas has been a Director of MedImmune Vaccines Inc. (formerly, Aviron) since August 2000. He has been a Director of Vical Inc. since May 1999. He serves as a Director at Protein Sciences Corporation. He serves as Director of NovaDigm Therapeutics, Inc. He serves as a Director of the International AIDS Vaccine Initiative and VaxInnate Inc. He serves on several other boards of Directors at biotechnology and non-profit associations focused on infectious diseases, world health, vaccines and pharmaceutical developments. Dr. Douglas serves as a Member of Advisory Board of PharmAthene, Inc. He served as a Director of EluSys Therapeutics Inc. He served as a Director of Intercell USA, Inc. (formerly, Iomai Corporation) from January 2003 to 2008. He served as Director of MiddleBrook Pharmaceuticals, Inc. from 1999 to August 3, 2010. Dr. Douglas is a member of the Institute of Medicine of the National Academies, the Association of American Physicians, the Infectious Diseases Society of America and the American Society of Clinical Investigation. He received his medical staff training at The New York Hospital and Johns Hopkins Hospital and is Board Certified in Internal Medicine. Dr. Douglas holds a Bachelor's Degree from Princeton University, an A.B. from Princeton University and an M.D. degree from Cornell University Medical College.

Corporate Headquarters -- --, -- -- United States Phone: -- Fax: -- Board Members Memberships Chairman of Advisory Board Elusys Therapeutics, Inc. Director Protein Sciences Corporation Director VaxInnate, Inc. Executive Chairman Aeras Global TB Vaccine Foundation Chairman NovaDigm Therapeutics, Inc. 1999-Present Chairman, Member of Audit Committee, Member of Nominating/Governance Committee and Member of Compensation Committee Vical Incorporated 1999-2010 Former Chairman of the Board, Member of Audit Committee and Member of Executive Committee MiddleBrook Pharmaceuticals, Inc. 2000-Present Director MedImmune Vaccines, Inc. 2003-2008 Former Director, Member of Audit Committee and Member of Compensation Committee Intercell USA, Inc. Education Bachelor's Degree Princeton University BA Princeton University MD Weill Cornell Medical College, New York Other Affiliations MedImmune Vaccines, Inc. Vical Incorporated Elusys Therapeutics, Inc. Hemispherx Biopharma, Inc. Protein Sciences Corporation Intercell USA, Inc. MiddleBrook Pharmaceuticals, Inc. Princeton University PharmAthene, Inc. VaxInnate, Inc. Weill Cornell Medical College, New York NovaDigm Therapeutics, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.